Funded Grants

The fight against ALS is made extremely challenging due to its largely unknown origin in most patients.

Depression is one of the most common mental health challenges faced by young people, yet choosing the right treatment remains a process of trial and error.

ALS is a devastatingly fatal neurodegenerative disease with patients losing their ability to walk, talk, eat, and interact with their loved ones.

Amyotrophic lateral sclerosis (known as ALS or Lou Gehrig’s disease) is a debilitating disease that causes loss of control over muscles and leads to death quickly after diagnosis.

Brain cancer is rarely curative and urgently needs novel transformative treatments.

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that affects the human motor system, leading to muscle weakness and ultimately paralysis.

While most forms of ALS occur in adulthood, mutations in the gene termed Serine Palmitoyltransferase Long Chain Base Subunit 1 (SPTLC1) arise in children.

Psychedelic drugs, known for their profound effects on perception, are showing promise as rapid and long-lasting treatments for depression.

While it is the immune system that damages the brain in MS, the way this damage is caused involves many processes.

Recent findings suggest that the gut and brain are closely connected, and this link may be important in Alzheimer’s disease (AD).